Erratum to: Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.
University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD, 21201, USA. medelman@umm.edu.
Martin J
MJ
Edelman
University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD, 21201, USA.
Rena
R
Lapidus
University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD, 21201, USA.
Josephine
J
Feliciano
Department of Nutrition, University of North Carolina, Chapel Hill, NC, USA.
Miroslav
M
Styblo
Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.|Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.|Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Jan H
JH
Beumer
University of Maryland School of Pharmacy, Baltimore, MD, USA.
Tao
T
Liu
University of Maryland School of Pharmacy, Baltimore, MD, USA.
Jogarao
J
Gobburu